Results 191 to 200 of about 3,355 (200)

Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum

Experimental Dermatology, 2011
Masamoto Murakami
exaly  

The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review

Dermatology and Therapy, 2017
Isabelle M Sanchez, Ethan Levin, Wilson J Liao   +2 more
exaly  

Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis

Journal of Investigative Dermatology, 2019
Barbara Meier-Schiesser, Laurence Feldmeyer, Mark Mellett   +2 more
exaly  

Acute generalized exanthematous pustulosis

2004
openaire   +1 more source

Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)

British Journal of Dermatology, 2007
exaly  

Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients

British Journal of Dermatology, 2013
exaly  

Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study

British Journal of Dermatology, 2013
exaly  

Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome

Rheumatology, 2008
exaly  

What do we know about palmoplantar pustulosis?

Journal of the European Academy of Dermatology and Venereology, 2017
exaly  

[Acute generalized exanthematic pustulosis].

Annales de dermatologie et de venereologie, 2001
L, Machet, L, Martin, L, Vaillant
openaire   +1 more source